Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This female subject was enrolled in a post-marketing surveillance open study 108160. On 29 January 2009, 03 March 2009 and 30 June 2009, she received the 1st, 2nd and 3rd dose of CERVARIX (IM deltoid) On 16 July 2009, 16 days after the 3rd dose of CERVARIX, this 25-year-old subject developed typhoid fever. The subject was hospitalised. The event resolved on 27 July 2009. The investigator considered that there was no reasonable possibility that the typhoid fever may have been caused by CERVARIX.
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166